This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Amelie Boulais
Head of Market Entry Strategy Viral-based Therapeutics at Sartorius Stedim Biotech


Amélie Boulais started her collaboration with Sartorius in 2008 as Application Specialist for the Purification Technologies division, responsible for South Europe. In 2012, she became membrane chromatography and virus clearance project manager, covering Europe. She was focusing on chromatography and virus clearance.She became Process Development Consultant team in 2015, supporting and advising actors of the bio-industry in their development from Upstream to final filling operations. She joined the Bioprocess Platform team in 2016, taking over the responsibility of the vaccine applications. She is now heading the Market Entry Strategy team within the Viral-based Therapeutics Segment. She is analyzing the trends of the gene therapy and vaccine industry in order to develop technology platforms with the required associated Process development support and related services for vaccine applications. Amélie is graduated from the ENSTBB (the Biotechnology Engineering institute of Bordeaux, France) and holds a Biotechnology Engineer degree.

Agenda Sessions

  • Expediting Viral Vector Vaccines Development in a Pandemic Situation